The Canadian Clinical Drug Data Set April 2025 release is now available for access and implementation on the Terminology Server and Terminology Gateway.
Learn More >
Important Update: We are pleased to announce significant enhancements to our FHIR Terminology Server, offering more seamless and standards-based access to terminology content for healthcare data exchange. Discover the new features and upcoming changes to our Terminology Gateway.
Learn More >
Hello,
My question relates to LOINC/pCLOCD code 46761-3 "Biotinidase deficiency newborn screen interpretation".
This test has a Component property of “Biotinidase deficiency”, but a Preferred Answer List with values like “In range”, “Borderline”, “Indeterminate”.
What does a “Biotinidase deficiency” of “In range” even mean? The deficiency is “in range” so the Biotinidase level is below normal? Or the Biotinidase level is “in range”, so there is no Biotinidase deficiency? Should the Component here just be “Biotinidase” or perhaps "Biotinidase level"?
Also, what happens if a different answer list with values like “Not deficient”, “Deficient”, “Deficient requiring further follow-up testing”, “Deficient requiring immediate intervention” is used? Then a Component of “Biotinidase deficiency” makes sense.
So there is ambiguity in how this LOINC could be interpreted, and its sense could be completely inverted depending on the answer list being used.
Am I putting too much stock in the Component property and Preferred Answer List?
Thoughts/feedback appreciated.
Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.